U.S.
CDC looking into heart inflammation in some young vaccine recipients
Send a link to a friend
[May 24, 2021]
By Radhika Anilkumar
(Reuters) -Some teenagers and young adults
who received COVID-19 vaccines experienced heart inflammation, a U.S.
Centers for Disease Control and Prevention advisory group said,
recommending further study of the rare condition.
|
The CDC's Advisory Committee on Immunization Practices in a
statement dated May 17 said it had looked into reports that a few
young vaccine recipients, predominantly adolescents and young
adults, and predominantly male, developed myocarditis, an
inflammation of the heart muscle.
The condition often goes away without complications and can be
caused by a variety of viruses, the CDC group said.
CDC monitoring systems had not found more cases than would be
expected in the population, but members of the committee on
vaccinations felt that healthcare providers should be made aware of
the reports of the "potential adverse event," the committee said in
the statement.
It did not say how many people had been affected and recommended
further investigation.
Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for
Health Security, said vaccines are known to cause myocarditis and
would be important to monitor to see if it is causally related to
the vaccine. It is important to look at the risk-benefit ratio, he
added. "Vaccines are going to unequivocally be much more beneficial
outweighing this very low, if conclusively established, risk."
The CDC said the cases typically occurred within four days after
receiving the mRNA vaccines. It did not specify which vaccines. The
United States has given emergency authorization to two mRNA
vaccines, from Moderna Inc and Pfizer/BioNTech.
[to top of second column] |
Israel's Health Ministry in
April said it was examining a small number of
cases of heart inflammation in people who had
received Pfizer's vaccine, though it had not yet
drawn any conclusions. Most of the cases in
Israel were reported among people up to age 30.
Pfizer at the time said it had not observed a higher rate of the
condition than would normally be the case in the general population
and that a causal link to the vaccine had not been established.
Pfizer and Moderna did not immediately respond to requests for
comment on Saturday.
The CDC in late April, after news of the Israeli investigation, said
it did not see a link between the two.
Earlier this month U.S. regulators expanded authorization of Pfizer
and BioNTech's COVID-19 vaccine to children aged 12 to 15.
The New York Times earlier reported on the CDC statement.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Leslie
Adler)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |